中國的DNA定序市場

預計在預測期（2025-2030 年），中國 DNA定序市場規模將以 21.5% 的複合年成長率擴大，從 2025 年的 12 億美元增至 2030 年底的 31 億美元。

中國 DNA定序市場的次世代定序(NGS) 部分預計在預測期 (2025-2030 年) 的複合年成長率將達到 22.1%，從 2025 年的 8.926 億美元成長到 2030 年底的 24 億美元。

中國 DNA定序市場的第三代定序部分預計在預測期內（2025-2030 年）將以 21.7% 的複合年成長率擴大，從 2025 年的 1.62 億美元增至 2030 年底的 4.32 億美元。

調查範圍

本報告概況了中國DNA定序市場並分析了市場趨勢。報告收益（百萬美元）和2025年的預估數據，以及截至2030年底的年複合成長率（CAGR）預測。市場分析涵蓋產品/服務、技術、應用、最終用戶和地區。本研究涵蓋的地區包括北京、上海、廣東等。

本報告中的「中國」指中國當地，不包括香港、澳門及台灣。中國當地共有31個省級行政區，包括22個省、4個省級市和5個省級自治區。本報告也涵蓋了北京市、上海市和廣東省。

該報告還重點介紹了創業投資和企業投資發展、監管趨勢、主要參與者的企業策略，以及人工智慧定序在精準醫療和群體基因組學計畫中衍生的潛在未來機會。報告結合了深入的市場預測、宏觀經濟分析和海關評估，使其成為相關人員、投資者和政策制定者了解和利用中國快速發展的DNA定序行業的重要資源。報告重點關注影響市場和供應商格局的關鍵驅動趨勢和挑戰，並分析了與市場相關的新興技術。

報告最後進行了競爭格局分析，提供了主要企業的排名和市場佔有率，還包括一個專門的公司簡介部分，其中包含主要企業的詳細資訊。

報告內容

• 16 個資料表和 40 個附加表
• 中國DNA測序技術市場概況及分析
• 中國市場趨勢分析，包括 2022 年至 2024 年的收益數據、2025 年的估計值以及 2030 年的複合年成長率預測
• 市場規模和收益估算，按產品/服務類型、技術、應用、最終用戶和地區進行市場佔有率分析
• 有關市場動態、機會和阻礙因素、技術進步、法規和宏觀經濟變數影響的事實和數據
• 波特五力模型與全球供應鏈分析的見解
• 下一代DNA測序技術及其在研究和臨床市場應用的新興趨勢和機會研究
• 產業結構分析，包括公司市場佔有率和排名、策略聯盟、併購活動和創業融資前景
• 華大基因、諾禾致源、貝瑞基因、安諾優達基因、燃石醫學等

目錄

第1章執行摘要

第2章 市場概況

• 概述和市場定義
• 波特五力分析
• 美國關稅的影響
• 對全球公司（例如 Illumina、Thermo Fisher Scientific）的直接影響
• 間接影響：促進中國國內成長與自給自足
• 市場結構及其對長期趨勢的影響

第3章 市場動態

• 市場動態
• 市場促進因素
• 政府投資和國家戰略舉措
• 創新與技術進步－讓定序變得經濟實惠
• 精準醫療和腫瘤基因組學的需求不斷成長
• 市場限制
• DNA測序技術高成本且操作障礙
• 監管複雜性和資料隱私挑戰
• 市場機遇
• 擴大精準醫療
• 擴大非侵入性產前檢測

第4章：監理現狀

• 中國DNA定序產業監管現狀
• 主要監管機構
• 人類遺傳資源（HGR）條例
• DNA定序的臨床應用

第5章 新興科技與發展

• 新興技術
• 長讀定序技術
• 單分子即時（SMRT）定序
• 奈米孔定序
• 空間基因組學和轉錄組學
• 單細胞DNA定序
• 超低輸入定序
• CRISPR-Cas9、基因組編輯和定序技術的整合
• DNA定序中的人工智慧（AI）和機器學習

第6章市場區隔分析

• 細分市場
• 中國DNA定序市場分析（依產品/服務）
• 設備和耗材
• 服務
• 中國DNA定序市場分析（依技術）
• 次世代定序（NGS）
• 第三代定序
• 桑格定序
• 焦磷酸測序
• 中國DNA定序市場分析（依應用）
• 生物製藥
• 微生物學
• 農業
• 中國DNA定序市場分析（依最終用戶）
• 學術研究機構
• 醫院和診所
• 製藥和生物技術公司
• 臨床研究
• 中國DNA定序市場分析（分省）
• 廣東省
• 北京
• 上海
• 其他區域市場

第7章 競爭態勢

• 概述
• 國內公司
• 國際公司

第8章 附錄

• 調查方法
• 參考
• 簡稱
• 公司簡介
• AGILENT TECHNOLOGIES INC.
• ANNOROAD GENE TECHNOLOGY
• BERRY GENOMICS
• BGI
• BURNING ROCK DX
• CAPITALBIO TECHNOLOGY CO. LTD.
• ILLUMINA INC.
• NOVOGENE CO. LTD.
• OXFORD NANOPORE TECHNOLOGIES PLC
• PACBIO
• THERMO FISHER SCIENTIFIC INC.
• 新興Start-Ups/市場顛覆者

The Chinese DNA sequencing market is expected to grow from $1.2 billion in 2025 and is projected to reach $3.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 21.5% during the forecast period of 2025 to 2030.

The Next-generation sequencing (NGS) segment of Chinese DNA sequencing market is expected to grow from $892.6 million in 2025 and is projected to reach $2.4 billion by the end of 2030, at a CAGR of 22.1% during the forecast period of 2025 to 2030.

The third-generation sequencing segment of Chinese DNA sequencing market is expected to grow from $162 million in 2025 and is projected to reach $432 million by the end of 2030, at a CAGR of 21.7% during the forecast period of 2025 to 2030.

Report Scope

This report provides an overview of the Chinese market for DNA sequencing and analyzes market trends. It includes revenue ($ million) for the base year data for 2024 and estimated data for 2025, and compound annual growth rate (CAGR) forecasts through the end of 2030. The market analyzed by products and services, technology, applications, end-users and provinces. The provinces covered in this study include Beijing, Shanghai, Guangdong and others.

In this report, "China" refers to mainland China and does not include Hong Kong, Macao, or Taiwan. Mainland China has 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Beijing, Shanghai and Guangdong are also discussed in this report.

The report also highlights developments related to venture capital and corporate investments, regulatory trends and enterprise strategies of key firms and potential future opportunities stemming from AI-driven sequences of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis and tariff assessments makes this report a critical resource for stakeholders, investors and policymakers seeking to understand and take advantage of the rapidly developing Chinese DNA sequencing sector. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It also analyzes emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking or share of key companies. It also has a dedicated section of company profiles that covers details of leading companies.

Report Includes

• 16 data tables and 40 additional tables
• Overview and an analysis of the Chinese market for DNA sequencing technologies
• Analyses of the Chinese market trends, with revenue data from 2022-2024, estimates for 2025, and projected CAGRs through 2030
• Estimates of the size and revenue prospects for the market, along with a market share analysis by product and service type, technology, application, end user and provinces
• Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations and the impacts of macroeconomic variables
• Insights derived from Porter's Five Forces model and global supply chain analysis
• Discussion of emerging trends and opportunities in next-generation DNA sequencing technologies and applications in research and clinical markets
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of the leading companies, including BGI, Novogene Co. Ltd., Berry Genomics, Annoroad Gene Technology, and Burning Rock Dx.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Technological Advances
• Market Dynamics and Growth Factors
• Segmental Analysis
• Conclusion

Chapter 2 Market Overview

• Overview and Market Definition
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Competition in the Industry
• Threat of Substitutes
• Impact of the U.S. Tariffs
• Direct Impact on Global Companies (e.g., Illumina, Thermo Fisher Scientific)
• Indirect Impact: Catalyzing Domestic Growth and Self-Sufficiency in China
• Impact on Market Structure and Long-Term Dynamics

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Government Investment and National Strategic Initiatives
• Innovation and Technological Advances - Making Sequencing Affordable
• Growing Demand for Precision Medicine and Oncology Genomics
• Market Restraints
• High Cost of DNA Sequencing Technologies and Operational Barriers
• Regulatory Complexity and Data Privacy Challenges
• Market Opportunities
• Expansion of Precision Medicine
• Growth in Non-invasive Prenatal Testing

Chapter 4 Regulatory Landscape

• Chinese DNA Sequencing Industry Regulatory Scenario
• Key Regulatory Authorities
• Human Genetic Resources (HGR) Regulations
• Clinical Use of DNA Sequencing

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies
• Long-Read Sequencing Technologies
• Single-Molecule Real-Time (SMRT) Sequencing
• Nanopore Sequencing
• Spatial Genomics and Transcriptomics
• Single-Cell DNA Sequencing
• Ultra-Low-Input Sequencing
• CRISPR-Cas9 and Genome Editing Integration with Sequencing Technologies
• Artificial Intelligence (AI) and Machine Learning in DNA Sequencing

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Chinese DNA Sequencing Market Analysis by Product and Service
• Instruments and Consumables
• Services
• Chinese DNA Sequencing Market Analysis, by Technology
• Next-Generation Sequencing (NGS)
• Third-Generation Sequencing
• Sanger Sequencing
• Pyrosequencing
• Chinese DNA Sequencing Market Analysis, by Application
• Biopharma
• Microbiology
• Agriculture
• Chinese DNA Sequencing Market Analysis, by End User
• Academic and Research Institutes
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Clinical Research
• Chinese DNA Sequencing Market Analysis, by Province
• Guangdong
• Beijing
• Shanghai
• Other Chinese Regional Markets

Chapter 7 Competitive Landscape

• Overview
• Domestic Companies
• International Companies

Chapter 8 Appendix

• Methodology
• References
• Abbreviations
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• ANNOROAD GENE TECHNOLOGY
• BERRY GENOMICS
• BGI
• BURNING ROCK DX
• CAPITALBIO TECHNOLOGY CO. LTD.
• ILLUMINA INC.
• NOVOGENE CO. LTD.
• OXFORD NANOPORE TECHNOLOGIES PLC
• PACBIO
• THERMO FISHER SCIENTIFIC INC.
• Emerging Start-ups/Market Disruptors

List of Tables

• Summary Table : Chinese Market for DNA Sequencing, by Technology, Through 2030
• Table 1 : Chinese Market for DNA Sequencing, by Product and Service, Through 2030
• Table 2 : DNA Sequencing Instruments and Consumables Offered by Major Companies
• Table 3 : Chinese Market for DNA Sequencing Instruments and Consumables, by Workflow, Through 2030
• Table 4 : Chinese Market for DNA Sequencing Services, by Workflow, Through 2030
• Table 5 : Chinese Market for DNA Sequencing, by Technology, Through 2030
• Table 6 : Chinese Market for DNA Sequencing, by Application, Through 2030
• Table 7 : Chinese Market for DNA Sequencing, by End User, Through 2030
• Table 8 : Chinese Market for DNA Sequencing, by Province, Through 2030
• Table 9 : Leading Chinese DNA Sequencing Companies, 2024
• Table 10 : Leading Chinese DNA Sequencing Companies' Strategic Developments, 2023-2025
• Table 11 : Information Sources for this Report
• Table 12 : Glossary of Terms Used in the Chinese DNA Sequencing Market
• Table 13 : Agilent Technologies Inc.: Company Snapshot
• Table 14 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
• Table 15 : Agilent Technologies Inc.: Product Portfolio
• Table 16 : Agilent Technologies Inc.: News/Key Developments, 2023-2024
• Table 17 : Annoroad Gene Technology: Company Snapshot
• Table 18 : Annoroad Gene Technology: Product Portfolio
• Table 19 : Annoroad Gene Technology: News/Key Developments, 2024
• Table 20 : Berry Genomics: Company Snapshot
• Table 21 : Berry Genomics: Financial Performance, FY 2023 and 2024
• Table 22 : Berry Genomics: Product Portfolio
• Table 23 : Berry Genomics: News/Key Developments, 2024-2025
• Table 24 : BGI: Company Snapshot
• Table 25 : BGI: Financial Performance, FY 2023 and 2024
• Table 26 : BGI: Product Portfolio
• Table 27 : BGI: News/Key Developments, 2025
• Table 28 : Burning Rock Dx: Company Snapshot
• Table 29 : Burning Rock Dx: Financial Performance, FY 2022 and 2023
• Table 30 : Burning Rock Dx: Product Portfolio
• Table 31 : Burning Rock Dx: News/Key Developments, 2023-2024
• Table 32 : CapitalBio Technology Co. Ltd.: Company Snapshot
• Table 33 : CapitalBio Technology Co. Ltd.: Product Portfolio
• Table 34 : CapitalBio Technology Co. Ltd.: News/Key Developments, 2024-2025
• Table 35 : Illumina Inc.: Company Snapshot
• Table 36 : Illumina Inc.: Financial Performance, FY 2023 and 2024
• Table 37 : Illumina Inc.: Product Portfolio
• Table 38 : Illumina Inc.: News/Key Developments, 2023-2024
• Table 39 : Novogene Co. Ltd.: Company Snapshot
• Table 40 : Novogene Co. Ltd.: Financial Performance, FY 2023 and 2024
• Table 41 : Novogene Co. Ltd.: Product Portfolio
• Table 42 : Novogene Co. Ltd.: News/Key Developments, 2023-2024
• Table 43 : Oxford Nanopore Technologies plc: Company Snapshot
• Table 44 : Oxford Nanopore Technologies plc: Financial Performance, FY 2023 and 2024
• Table 45 : Oxford Nanopore Technologies plc: Product Portfolio
• Table 46 : Oxford Nanopore Technologies plc: News/Key Developments, 2024
• Table 47 : PacBio: Company Snapshot
• Table 48 : PacBio: Financial Performance, FY 2023 and 2024
• Table 49 : PacBio: Product Portfolio
• Table 50 : PacBio: News/Key Developments, 2023-2024
• Table 51 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 52 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
• Table 53 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 54 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023-2025
• Table 55 : List of Few Emerging Startups in the Chinese market for DNA sequencing

List of Figures

• Summary Figure : Chinese Market Shares of DNA Sequencing, by Technology, 2024
• Figure 1 : Porter's Five Forces Analysis of the Chinese DNA Sequencing Market
• Figure 2 : Market Dynamics Snapshot of Chinese DNA Sequencing
• Figure 3 : Chinese Market Shares of DNA Sequencing, by Product and Service, 2024
• Figure 4 : Chinese Market Shares of DNA Sequencing, by Technology, 2024
• Figure 5 : Different NGS Technologies and Their Applications
• Figure 6 : Chinese Market Shares of DNA Sequencing, by Application, 2024
• Figure 7 : Chinese Market Shares of DNA Sequencing, by End User, 2024
• Figure 8 : Chinese Market Shares of DNA Sequencing, by Province, 2024
• Figure 9 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 10 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 11 : BGI: Revenue Shares, by Business Unit, FY 2024
• Figure 12 : BGI: Revenue Shares, by Country/Region, FY 2024
• Figure 13 : Burning Rock Dx: Revenue Shares, by Business Segment, FY 2024
• Figure 14 : Burning Rock Dx: Revenue Shares, by Country/Region, FY 2024
• Figure 15 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 16 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 17 : Oxford Nanopore Technologies plc: Revenue Shares, by Country/Region, FY 2024
• Figure 18 : PACBIO: Revenue Shares, by Business Unit, FY 2024
• Figure 19 : PACBIO: Revenue Shares, by Country/Region, FY 2024
• Figure 20 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 21 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024